Health and Fitness Health and Fitness
Mon, September 24, 2012
Sun, September 23, 2012
Fri, September 21, 2012
Thu, September 20, 2012
Wed, September 19, 2012
Tue, September 18, 2012
Mon, September 17, 2012
Sun, September 16, 2012
Fri, September 14, 2012
Thu, September 13, 2012
Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012

Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference


//health-fitness.news-articles.net/content/2012/ .. sent-at-ubs-global-life-sciences-conference.html
Published in Health and Fitness on Friday, September 14th 2012 at 5:48 GMT by Market Wire   Print publication without navigation


Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference -- ALISO VIEJO, Calif., Sept. 14, 2012 /PRNewswire/ --

Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference

[ ]

ALISO VIEJO, Calif., Sept. 14, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) today announced that company management will present an overview of the company at the UBS Global Life Sciences Conference in New York, NY.

  • Location: Grand Hyatt, New York, NY
  • Presentation date: Thursday September 20, 2012
  • Presentation time: 11:30 a.m. ET

A live webcast and 30-day archive of this presentation will be available at [ http://ir.avanir.com ].

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
[ ir@avanir.com ]
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ www.avanir.com ]


Publication Contributing Sources